For the Quarter Ending June 2026
Metformin HCL Prices in APAC
- In South Korea, the Metformin HCL Price Index rose by 14.43% quarter-over-quarter, reflecting landed import costs.
- The average Metformin HCL price for the quarter was approximately USD 3035.00/MT, on CFR Busan terms.
- Metformin HCL Spot Price fell sharply in June as exporters increased volumes, pressuring CFR Busan offers.
- Metformin HCL Price Forecast indicates transient recovery into July as buyers restock and suppliers tighten offers.
- Metformin Production Cost Trend rose at origins due to higher feedstock and environmental compliance surcharges.
- Metformin HCL Demand Outlook remains steady, supported by clinical preference and hospital procurement ahead of reviews.
- Metformin HCL Price Index volatility eased as Busan inventories rebuilt, allowing suppliers to restore offer levels.
- Large Chinese and Indian exporters resumed post-maintenance shipments, expanding prompt availability and exerting downward pricing pressure.
Why did the price of Metformin HCL change in June 2026 in APAC?
- Rising Chinese and Indian export volumes increased Busan arrivals, rebuilding inventories and pressuring domestic prices.
- Higher feedstock and environmental surcharges at origin raised production costs, supporting exporters' higher offer levels.
- Buyer front-loading ahead of reimbursement review temporarily tightened inventories, later reducing spot enquiries in June.
China
- In China, the Metformin Price Index rose by 14.73% quarter-over-quarter, from tighter exports and surging offtake.
- Shanghai inventories rose then drew down, influencing Metformin Spot Price and seller offer adjustments amid audits.
India
- In India, the Metformin Price Index rose by 27.22% quarter-over-quarter, reflecting supply tightness and export diversion.
- Metformin Spot Price remained firm as western Indian inventories tightened and exporters prioritised overseas contracts.
Metformin HCL Prices in Europe
- In Germany, the Metformin Hydrochloride Price Index rose by 14.88% quarter-over-quarter, driven by restocking pressures.
- The average Metformin Hydrochloride price for the quarter was approximately USD 3150/MT including freight adjustments.
- Sustained discounts and improved container availability lifted Metformin Hydrochloride Spot Price momentum at Hamburg port.
- Short-term Metformin Hydrochloride Price Forecast suggests moderate recovery as buyers absorb discounted prompt material volumes.
- Metformin Hydrochloride Production Cost Trend eased as upstream solvent and energy prices moderated through May.
- Metformin Hydrochloride Demand Outlook remains steady with structural prescription growth and hospital tender acceleration activity.
- Price Index movement reflected high port stocks, slowed customs releases, and inventory adjustments across Germany.
- Asian supplier operating rates and orderly shipping schedules restrained prompt availability, shaping CFR offers notably.
Why did the price of Metformin Hydrochloride change in June 2026 in Europe?
- Aggressive discounted offers from India and China increased arrivals, overwhelming April restocking and pressuring quotations.
- EU nitrosamine testing and customs delays extended release times, intermittently constraining prompt availability despite shipments.
- Wartime route diversions increased freight and insurance costs, raising landed costs and prompting offer adjustments.
Metformin HCL Prices in North America
- In the US, the Metformin Hydrochloride Price Index showed a firm upward trend, driven by freight escalation and steady prescription-led demand.
- The Metformin Hydrochloride price trend reflected elevated trans-Pacific logistics costs and disciplined Asian FOB offers.
- The Metformin Hydrochloride Spot Price remained supported as importers balanced discounted Asian offers with longer transit times and insurance pressure.
- The Metformin Hydrochloride Price Forecast indicates moderate firmness as seasonal demand and import constraints persist.
- The Metformin Hydrochloride Production Cost Trend eased slightly with stable feedstocks, though logistics-driven costs kept landed values elevated.
- The Metformin Hydrochloride Demand Outlook stayed strong, supported by structural prescription growth and consistent institutional procurement.
- Inventory drawdowns and cautious June purchasing shaped Price Index movement, tempering upside despite firm logistics costs.
- Asian suppliers maintained stable operating rates, but rerouting and extended transit times elevated US landed-cost pressure.
Why did the price of Metformin Hydrochloride change in June 2026 in North America?
- Higher Asia–US freight and insurance raised landed costs, supporting firmer June Metformin offers.
- Strong arrivals from India and China pressured quotations, though logistics costs limited deeper declines.
- Steady prescription demand absorbed available volumes, smoothing June price movements across US channels.
For the Quarter Ending March 2026
Metformin HCL Prices in APAC
- In South Korea, the Metformin Hydrochloride Price Index rose by 2.41% quarter-over-quarter, reflecting tighter March supply.
- The average Metformin Hydrochloride price for the quarter was approximately USD 2652.33/MT, reported by importers and distributors.
- Metformin Hydrochloride Spot Price tightened in March as Chinese and Indian allocations prioritized domestic and US contracts.
- Metformin Hydrochloride Price Forecast indicates April increases driven by restocking, inventory drawdowns, and freight cost pressures overall.
- Metformin Hydrochloride Production Cost Trend rose from LNG-linked utility increases, lifting Chinese FOB quotations and Busan costs.
- Metformin Hydrochloride Demand Outlook remains steady as NHIS reimbursement support and chronic-disease prescriptions sustain baseline consumption levels.
- Distributor inventories tightened to around four weeks, supporting the Metformin Hydrochloride Price Index and firmer dealer offers.
- Chinese plant documentation upgrades and Indian US-bound shipments reduced export surplus, amplifying Busan Price Index pressure.
Why did the price of Metformin Hydrochloride change in March 2026 in APAC?
- Export supply tightened as Chinese documentation upgrades and Indian shipments diverted to the US reduced Korean allotments.
- LNG price rebound raised Chinese utility costs, lifting FOB offers and increasing landed import costs into Busan.
- Korean formulators advanced orders ahead of NHIS reimbursement review, thereby intensifying competition for the limited March parcel availability.
Metformin HCL Prices in Europe
- In Germany, the Metformin Price Index rose by 2.95% quarter-over-quarter, reflecting tighter post-nitrosamine availability recently.
- The average Metformin price for the quarter was approximately USD 2742.00/MT across import and domestic supply channels.
- Metformin Spot Price tightened in March as distributors reduced available lots, supporting firmer offers nationwide.
- Metformin Price Forecast indicates modest gains near-term, supported by selective restocking and tighter shipments abroad.
- Metformin Production Cost Trend showed upward pressure from higher Asian FOBs, freight, and raw-material expenses.
- Metformin Demand Outlook remains structurally firm due to the ageing population and steady reimbursed prescription volumes.
- Metformin Price Index volatility is limited by AMNOG reference pricing, constraining pass-through of upstream cost increases.
- Inventory levels stayed around three weeks, preventing shortages while port operations in Hamburg remained smooth.
Why did the price of Metformin change in March 2026 in Europe?
- Tighter imported availability due to extended-release testing and documentation reduced spot cargoes into Hamburg.
- Elevated freight and higher Asian FOB quotations increased landed costs, prompting importers to accelerate purchases.
- Robust domestic offtake from formulators and hospital tendering absorbed volumes, limiting downward pressure on prices.
Metformin HCL Prices in North America
- In the USA, the Metformin Price Index rose quarter-over-quarter, reflecting tighter import availability and firm underlying demand.
- Metformin Spot Price strengthened in March as reduced shipment availability and distributor inventory control tightened prompt supply.
- Metformin Production Cost Trend showed upward pressure, driven by higher Asian FOB prices, freight costs, and raw material expenses.
- Metformin Demand Outlook remained structurally strong, supported by consistent prescription volumes and ongoing demand from the healthcare sector.
- Metformin Price Forecast indicates modest near-term gains, driven by restocking activity and constrained import flows.
- Inventory levels across US distribution channels remained adequate but slightly tighter due to steady consumption and delayed replenishment.
- Import reliance on Asian suppliers exposed the market to supply constraints linked to compliance and extended testing requirements.
- Suppliers maintained firm pricing discipline, balancing cost increases with steady demand and controlled inventory releases.
Why did the price of Metformin change in March 2026 in North America?
- Reduced export availability due to extended testing and documentation requirements limited incoming shipments.
- Higher freight rates and increased Asian FOB prices raised landed import costs.
- Strong domestic demand from formulators and healthcare procurement absorbed supply, supporting firmer pricing.
For the Quarter Ending December 2025
APAC
- In South Korea, the Metformin HCL Price Index fell by 0.61% quarter-over-quarter, reflecting feedstock pressure.
- The average Metformin HCL price for the quarter was approximately USD 3982.00/MT, reported CFR Busan.
- Metformin HCL Spot Price remained muted as steady imports and balanced inventories constrained supplier offers.
- Metformin HCL Price Forecast expects modest initial weakness followed by recovery driven by selective restocking.
- Metformin HCL Production Cost Trend showed mild upward pressure from energy and intermediate feedstock costs.
- Metformin HCL Demand Outlook remains steady as diabetes prevalence supports consumption and disciplined procurement continues.
- Metformin HCL Price Index benefited from Busan logistics and competitive Chinese and Indian export offers.
- Distributor inventories and balanced domestic output limited urgent buying, restraining spikes, and preserving market balance.
Why did the price of Metformin HCL change in December 2025 in APAC?
- Balanced imports from China and India met steady demand, keeping December price movement slightly negative.
- Stable freight and Busan port operations removed logistics premiums, preventing landed cost pressure on offers.
- Comfortable inventories and disciplined procurement by manufacturers limited spot buying, curbing upward price momentum in December.
Europe
- In Germany, the Metformin Price Index fell by 0.79% quarter-over-quarter, reflecting steady imports and procurement.
- The average Metformin price for the quarter was approximately USD 4053.00/MT, reflecting range-bound traded levels.
- Metformin Spot Price movements were subdued as abundant Asian shipments and distributor buying limited volatility.
- Metformin Price Forecast projects modest weakness early Q1 due to inventory overhang and spot purchasing.
- Metformin Production Cost Trend showed upward pressure from feedstock and energy, affecting landed CFR Hamburg costs.
- Metformin Demand Outlook remains stable with steady pharmaceutical offtake, restrained spot buying, and predictable prescription-driven consumption.
- Metformin Price Index reflected mild downward pressure as reference-price caps and tendering capped seller leverage.
- Inventory buffers and export flows from India and China limited restocking, keeping short-term offers subdued.
Why did the price of Metformin change in December 2025 in Europe?
- Ample imports from India and China matched demand, creating inventory overhang and reducing seller pricing power.
- Reference-price caps and completed year-end tenders restrained formulators, limiting spot buying and post-holiday procurement activity.
- Moderate feedstock and freight pressures marginally lowered landed costs, not triggering significant upward price movement.
North America
- In North America, the Metformin Price Index declined slightly quarter-over-quarter, reflecting stable import flows and measured procurement.
- Metformin market conditions remained import-led, with India and China supplying most shipments for pharmaceutical distributors and hospitals.
- Metformin Spot Price movements were subdued as abundant Asian-origin cargoes and adequate distributor inventories limited short-term volatility.
- Metformin Price Forecast signals modest weakness early 2026, due to inventory overhang and cautious year-end purchasing by formulators.
- Metformin Production Cost Trend for importers showed moderate upward pressure from feedstock and energy costs, partially offset by stable freight.
- Metformin Demand Outlook remained steady, with routine pharmaceutical offtake and prescription-driven consumption balancing subdued spot buying.
- Price Index reflected mild downward pressure as reference-price caps, tenders, and year-end order timing constrained importer leverage.
- Distributor and hospital inventories remained adequate, preventing urgent restocking and maintaining near-term price stability.
Why did the price of Metformin change in December 2025 in North America?
- Ample imports from India and China met demand, creating inventory overhang and limiting spot price gains.
- Reference-price caps and completed year-end tenders restrained formulators, curbing immediate buying activity.
- Moderate feedstock and freight pressures kept landed costs stable, preventing significant upward price movement.
For the Quarter Ending September 2025
APAC
- In South Korea, the Metformin HCL Price Index fell by 14.17% quarter-over-quarter, driven by excess inventories.
- The average Metformin HCL price for the quarter was approximately USD 4006.33/MT, reflecting subdued purchasing activity.
- Metformin HCL Spot Price weakened as Asian export offers softened and landed costs declined, pressuring domestic margins.
- Metformin HCL Price Forecast shows modest volatility with alternating mild declines and brief recoveries through near term.
- Metformin HCL Production Cost Trend eased due to lower raw material costs and favourable USD-KRW movements reducing import expenses.
- Metformin HCL Demand Outlook remains weak with downstream pharmaceuticals and API manufacturers deferring restocking amid ample inventories.
- Export volumes stayed steady while domestic suppliers discounted stock, keeping the Metformin HCL Price Index under downward pressure.
- Major supplier production remained stable, but elevated distributor inventories and cautious procurement constrained upside momentum.
Why did the price of Metformin HCL change in September 2025 in APAC?
- Ample import supplies and discounted Asian export offers increased available volumes, reducing landed costs and price pressure.
- High domestic inventories prompted buyers to delay orders, suppressing procurement and weakening short term demand.
- Lower raw material costs and favourable USD KRW exchange reduced production and import costs, offset slightly by freight.
Europe
- In Germany, the Metformin Price Index fell by 13.08% quarter-over-quarter, driven by import cuts and inventory overhang.
- The average Metformin price for the quarter was approximately USD 4085.33/MT amid subdued procurement activity.
- Metformin Spot Price weakness reflected discounted Asian offers and cautious German buyers delaying replenishment orders.
- Metformin Price Forecast suggests marginal volatility as end-user inquiries slowly recover and inventories normalize gradually.
- Metformin Production Cost Trend benefited from weaker USD and Asian offers, partially offset by freight.
- Metformin Demand Outlook remains muted, keeping Metformin Price Index pressured amid weak pharmaceutical procurement activity.
- Elevated inventories and steady export flows constrained trading, limiting any uptick in Metformin Spot Price.
- Major producers ran steady volumes, limiting disruption risk and supporting balanced Metformin Price Index dynamics.
Why did the price of Metformin change in September 2025 in Europe?
- Abundant Asian export offers and high domestic inventories reduced procurement urgency, driving Metformin downward pressure.
- Weaker USD lowered import costs, while rising freight rates offset savings for landed Metformin shipments.
- Cautious pharmaceutical procurement and soft downstream consumption constrained buying, sustaining weak Metformin Price Index momentum.
North America
- In the USA, the Metformin Price Index declined quarter-over-quarter, reflecting high inventories and weaker import demand from Asia.
- Metformin Spot Price softened as suppliers offered discounts to clear stock, while U.S. buyers delayed orders amid muted pharmaceutical consumption.
- Metformin Price Forecast indicates limited near-term recovery, with expectations of stabilization as downstream restocking resumes gradually.
- Metformin Production Cost Trend for importers eased with lower Asian export quotations and steady freight costs helping moderate landed expenses.
- Metformin Demand Outlook remains subdued, with healthcare and generic drug manufacturers maintaining cautious procurement patterns.
- Elevated inventories and subdued import activity weighed on Metformin Price Index performance across key distribution hubs.
- Competitive pricing among Asian exporters pressured landed cost margins, keeping Metformin Spot Price constrained in the U.S. market.
- Smooth logistics and consistent shipping schedules ensured supply continuity, minimizing volatility despite the weak demand environment.
Why did the price of Metformin change in September 2025 in North America?
- Ample supply from Asian exporters and existing domestic inventories reduced procurement urgency, pushing prices lower.
- Subdued downstream demand and delayed restocking limited transactional activity, maintaining weak market sentiment.
- Stable freight rates and smoother import operations partially offset cost pressures but were insufficient to support price recovery.
